SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial)
- the ACTIV-3/VATICO study group and the STRIVE Network
- , Clinical Sites by Country
- , INSIGHT Community Advisory Board
- , Statistical and Data Management Center, Division of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, Minnesota, United States
- , Foundation for the National Institutes of Health, Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) and Operation Warp Speed, North Bethesda, Maryland, United States
- , Frederick National Laboratory for Cancer Research/Leidos Biomedical Research, Inc., Frederick, Maryland, United States
- , US. National Institute of Allergy and Infectious Diseases (including Department of Clinical Research International Coordinating Center), Bethesda, Maryland, United States
- , Washington ICC, Veterans Affairs Medical Center, Washington, DC, United States
- , Veterans Affairs ICC, US Department of Veterans Affairs, Washington DC, United States
- , Sydney ICC, The Kirby Institute, University of New South Wales, Sydney, Australia
- , Nashville ICC, Vanderbilt University Medical Center, Nashville, Tennessee, United States
- , London ICC, MRC Clinical Trials Unit at UCL, London, United Kingdom
- , Copenhagen ICC, CHIP (Centre of Excellence for Health, Immunity and Infections), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
- , Cardiothoracic Surgical Trials Network (CTSN) ICC, Icahn School of Medicine at Mount Sinai, New York, New York, United States
- , International Coordinating Centers (ICCs)
Research output: Contribution to journal › Article › peer-review
1
Scopus
citations